Compare Nuwellis Inc (NUWE) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Zoom Video Communications, Inc. — how do they compare? Nuwellis Inc trades at $0.7 (market cap $2.20M), while Zoom Video Communications, Inc. trades at $96.5 (market cap $27.62B). The key difference: Zoom Video Communications, Inc. is far larger — about 12554.5× Nuwellis Inc's market cap, and Zoom Video Communications, Inc. is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Zoom Video Communications, Inc. for 92 Days on average.
| NUWE | ZM | |
|---|---|---|
Market Cap | $2.20M | $27.62B |
Volume | 121,544 | 3,913,188 |
Sector | Health | Technology |
52-Week High | $146.65 | $111.88 |
52-Week Low | $0.68 | $72.72 |
Typical Hold Time | 26 Days | 92 Days |
Enterprise Value | -$1.52M | $20.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Zoom Communications (ZM) trades at $94.77, up 0.61% with a bullish technical outlook. The stock shows strong profitability with 77.3% gross margins and 65.19% net income margin, supported by recent earnings beats. Analyst consensus targets $118.08 with 38.8% buy ratings. Recent AI product launches and board appointments signal strategic growth initiatives.
Zoom presents a compelling investment case with attractive valuation (P/E 8.79) and robust profitability, though near-term risks include competitive pressures and reliance on international sales. The stock's proximity to resistance at $95 requires monitoring, but institutional interest and AI-driven revenue initiatives support long-term upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
